Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Tilray Inc buy AdvisoryRally59

Start price
€1.52
25.06.24 / 50%
Target price
-
25.07.24
Performance (%)
2.07%
Price
€1.56
28.06.24
Summary
This prediction is currently active. The BUY prediction by AdvisoryRally59 shows slight gains of 2.07%. This prediction currently runs until 25.07.24. The prediction end date can be changed by AdvisoryRally59 at any time. AdvisoryRally59 has 50% into this prediction

Tilray, Inc. is a Canadian-based pharmaceutical and cannabis company that is listed on the NASDAQ exchange under the ticker symbol TLRY. The company specializes in the research, cultivation, production, and distribution of medical cannabis products worldwide. Founded in 2013, Tilray has become one of the largest cannabis companies in the world with operations in North America, Europe, and Australia. The company's main areas of focus are medical research and development, consumer brands, as well as global distribution partnerships. As a publicly traded company, Tilray's stock price is subject to market fluctuations and investor sentiment towards the cannabis industry.

Performance without dividends (%)
Name 1w
Tilray Inc 2.07%
iShares Core DAX® 0.238%
iShares Nasdaq 100 -0.304%
iShares Nikkei 225® 2.271%
iShares S&P 500 -0.296%

Comments by AdvisoryRally59 for this prediction